E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/9/2019 in the Prospect News Structured Products Daily.

New Issue: JPMorgan prices $1.2 million contingent interest autocalls on two stocks

By Sarah Lizee

Olympia, Wash., Dec. 9 – JPMorgan Chase Financial Co. LLC priced $1.2 million of autocallable contingent interest notes due Nov. 30, 2022 linked to the least performing of the common stocks of Amgen Inc. and Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

Each quarter, the notes will pay a contingent coupon at the rate of 9.35% per year if each stock closes at or above its interest barrier, 75% of its initial share price, on the review date for that period.

The notes will be automatically called at par plus the contingent coupon if each stock closes at or above its initial share price on any quarterly review date other than the first and final dates.

If the notes have not been called, the payout at maturity will be par unless any stock finishes below its buffer level, 75% of its initial level, in which case investors will lose 1.33333% for every 1% that the least-performing stock declines beyond 25%.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase Financial Co. LLC
Guarantor:JPMorgan Chase & Co.
Issue:Autocallable contingent interest notes
Underlying stocks:Amgen Inc. and Pfizer Inc.
Amount:$1.2 million
Maturity:Nov. 30, 2022
Coupon:9.35% per year, payable quarterly if each stock closes at or above interest barrier value on review date for that quarter
Price:Par
Payout at maturity:Par plus contingent coupon if each stock finishes at or above buffer value; otherwise, 1.33333% for every 1% that the least-performing stock declines beyond 25%
Call:Automatically at par plus contingent coupon if each stock closes at or above initial price on any review date other than the first and final dates
Initial share prices:$234.54 for Amgen, $38.68 for Pfizer
Coupon barriers:$175.905 for Amgen, $29.01 for Pfizer; 75% of initial share prices
Buffer levels:$175.905 for Amgen, $29.01 for Pfizer; 75% of initial share prices
Pricing date:Nov. 25
Settlement date:Nov. 29
Agent:J.P. Morgan Securities LLC
Fees:0.25%
Cusip:48132FV45

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.